[Effect of pyracetam on the color discriminative function of retina in patients with craniocerebral trauma]. 2003

K B Ovanesov, and I B Shikina, and E B Arushanian, and I Iu Shchurovskaia
Department of Pharmacology, State Medical Academy, ul. Mira 310, Stavropol, 355024 Russia.

The chronic administration of piracetam over a period of four weeks in patients after heavy craniocerebral traumas significantly improves the color discrimination of retina with respect to all four colors studied. It is suggested that the improved functioning is related to the nootrope effect upon the GABAergic processes both in the retina and in the related cerebral structures.

UI MeSH Term Description Entries
D008297 Male Males
D010889 Piracetam A compound suggested to be both a nootropic and a neuroprotective agent. 2-Pyrrolidone-N-Acetamide,Avigilen,Axonyl,Cerebroforte,Cerepar N,Ciclofalina,Cuxabrain,Dinagen,Gabacet,Geram,Memo-Puren,Nootrop,Nootropil,Nootropyl,Normabraïn,Piracebral,Piracetam AbZ,Piracetam-RPh,Piracetrop,Pirazetam,Pyracetam,Pyramem,Sinapsan,UCB-6215,Memo Puren,Piracetam RPh,UCB 6215,UCB6215
D012160 Retina The ten-layered nervous tissue membrane of the eye. It is continuous with the OPTIC NERVE and receives images of external objects and transmits visual impulses to the brain. Its outer surface is in contact with the CHOROID and the inner surface with the VITREOUS BODY. The outer-most layer is pigmented, whereas the inner nine layers are transparent. Ora Serrata
D003118 Color Perception Mental processing of chromatic signals (COLOR VISION) from the eye by the VISUAL CORTEX where they are converted into symbolic representations. Color perception involves numerous neurons, and is influenced not only by the distribution of wavelengths from the viewed object, but also by its background color and brightness contrast at its boundary. Color Perceptions,Perception, Color,Perceptions, Color
D005260 Female Females
D006259 Craniocerebral Trauma Traumatic injuries involving the cranium and intracranial structures (i.e., BRAIN; CRANIAL NERVES; MENINGES; and other structures). Injuries may be classified by whether or not the skull is penetrated (i.e., penetrating vs. nonpenetrating) or whether there is an associated hemorrhage. Frontal Region Trauma,Head Injuries,Head Trauma,Occipital Region Trauma,Parietal Region Trauma,Temporal Region Trauma,Craniocerebral Injuries,Crushing Skull Injury,Forehead Trauma,Head Injuries, Multiple,Head Injury, Minor,Head Injury, Open,Head Injury, Superficial,Injuries, Craniocerebral,Injuries, Head,Multiple Head Injuries,Occipital Trauma,Open Head Injury,Superficial Head Injury,Trauma, Head,Craniocerebral Injury,Craniocerebral Traumas,Crushing Skull Injuries,Forehead Traumas,Frontal Region Traumas,Head Injuries, Minor,Head Injuries, Open,Head Injuries, Superficial,Head Injury,Head Injury, Multiple,Head Traumas,Injuries, Minor Head,Injuries, Multiple Head,Injuries, Open Head,Injuries, Superficial Head,Injury, Craniocerebral,Injury, Head,Injury, Minor Head,Injury, Multiple Head,Injury, Open Head,Injury, Superficial Head,Minor Head Injuries,Minor Head Injury,Multiple Head Injury,Occipital Region Traumas,Occipital Traumas,Open Head Injuries,Parietal Region Traumas,Region Trauma, Frontal,Region Trauma, Occipital,Region Trauma, Parietal,Region Traumas, Frontal,Region Traumas, Occipital,Region Traumas, Parietal,Skull Injuries, Crushing,Skull Injury, Crushing,Superficial Head Injuries,Temporal Region Traumas,Trauma, Craniocerebral,Trauma, Forehead,Trauma, Frontal Region,Trauma, Occipital,Trauma, Occipital Region,Trauma, Parietal Region,Trauma, Temporal Region,Traumas, Craniocerebral,Traumas, Forehead,Traumas, Frontal Region,Traumas, Head,Traumas, Occipital,Traumas, Occipital Region,Traumas, Parietal Region,Traumas, Temporal Region
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D018697 Nootropic Agents Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. Anti-Dementia Agent,Antidementia Agent,Cognitive Enhancer,Cognitive Enhancers,Nootropic,Nootropic Agent,Nootropic Drug,Procognitive Agent,Anti-Dementia Agents,Antidementia Agents,Nootropic Drugs,Nootropics,Procognitive Agents,Agent, Anti-Dementia,Agent, Antidementia,Agent, Nootropic,Agent, Procognitive,Agents, Anti-Dementia,Agents, Antidementia,Agents, Nootropic,Agents, Procognitive,Anti Dementia Agent,Anti Dementia Agents,Drug, Nootropic,Drugs, Nootropic,Enhancer, Cognitive,Enhancers, Cognitive

Related Publications

K B Ovanesov, and I B Shikina, and E B Arushanian, and I Iu Shchurovskaia
August 2023, Minerva pediatrics,
K B Ovanesov, and I B Shikina, and E B Arushanian, and I Iu Shchurovskaia
January 1995, Zentralblatt fur Chirurgie,
K B Ovanesov, and I B Shikina, and E B Arushanian, and I Iu Shchurovskaia
January 1998, Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko,
K B Ovanesov, and I B Shikina, and E B Arushanian, and I Iu Shchurovskaia
January 2006, Vestnik otorinolaringologii,
K B Ovanesov, and I B Shikina, and E B Arushanian, and I Iu Shchurovskaia
October 1990, Neurologia (Barcelona, Spain),
K B Ovanesov, and I B Shikina, and E B Arushanian, and I Iu Shchurovskaia
January 2002, Anesteziologiia i reanimatologiia,
K B Ovanesov, and I B Shikina, and E B Arushanian, and I Iu Shchurovskaia
January 1998, Eksperimental'naia i klinicheskaia farmakologiia,
K B Ovanesov, and I B Shikina, and E B Arushanian, and I Iu Shchurovskaia
January 1997, Zentralblatt fur Neurochirurgie,
K B Ovanesov, and I B Shikina, and E B Arushanian, and I Iu Shchurovskaia
January 1993, Likars'ka sprava,
K B Ovanesov, and I B Shikina, and E B Arushanian, and I Iu Shchurovskaia
December 1989, Vrachebnoe delo,
Copied contents to your clipboard!